SV40 in vaccines

Did polio vaccines contaminated with SV40 cause increased incidence of rare cancers and non-Hodgkin lymphoma?

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ATLANTA — The US Institute of Medicine (IOM) is looking into whether polio vaccines contaminated with the simian virus SV40 — thought to inactivate p53 and Rb — and given 40 years ago have caused a spike in the incidence of several cancers.

As much as two-thirds of the oral Sabin and injected Salk polio vaccine supply given from 1955 to 1963 in the US, Australia, Canada, Germany and other countries was contaminated with SV40, according to a recent report in the Wall Street Journal. Since then, the incidence of certain rare cancers such as the brain cancer ependymoma has increased 25%; osteosarcomas are up 23%; and the incidence of mesothelioma, a lung cancer strongly linked to asbestos exposure, has soared 90%. The incidence of non-Hodgkin lymphoma, not a rare cancer, has increased by 82% since 1973. A total of 56,200 new cases and 24,000 deaths from non-Hodgkin lymphoma were ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Emma Hitt

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio